Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ANI PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 45
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

NORVIUM BIOSCIENCE

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 47
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

ANI PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 35
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 49
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 44
  • 0 comments

FDA approve MECLOFENAMATE SODIUM

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 51
  • 0 comments

FDA approve MECLOFENAMATE SODIUM

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 43
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 45
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 38
  • 0 comments

FDA approve SULINDAC

Comment Full text

KEY THERAP

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 56
  • 0 comments

FDA approve FENOPROFEN CALCIUM

Comment Full text
  • Previous
  • 304
  • 305
  • 306
  • 307
  • 308
  • Next

Search

News categories

  • Technical Exchange News(11495)
  • Event(3336)
  • SEC News(215299)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137305)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin